Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal moisture regulation refers to the combined actions of various molecular and cellular processes that govern the absorption and secretion of water and electrolytes across the intestinal epithelium. Key players include ion channels such as the cystic fibrosis transmembrane conductance regulator (CFTR), sodium-glucose co-transporter 1 (SGLT1), sodium/hydrogen exchanger 3 (NHE3), and aquaporins, along with hormonal (e.g., secretin) and mucosal (e.g., MUC2 mucin) regulators[3][2][6]. These elements maintain fluid balance by finely tuning water movement into and out of the intestinal lumen, which is vital for digestion, nutrient absorption, and maintenance of the mucosal barrier. Disruption of these processes can result in clinical conditions such as diarrhea, constipation, or inflammatory diseases[3][2][6]. Since "Intestinal moisture regulation" describes a physiological *function* rather than a single molecular entity, it is not a standard therapeutic target designation. If you require information on a specific molecule, such as CFTR, aquaporins, or epithelial sodium channels (ENaC) involved in this process, please specify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal moisture regulation.